nba ゲーム E-Gel,HINEX E-Gel LC,HINEXResearch nba 結果 Development
The research nba 結果 development of drugs takes long years nba 結果 persevering effort. We perform verifications to assure a product’s safety nba 結果 efficacy, followed by a careful validation of the product’s efficacy through clinical trials.
It takes the constant effort of many people before our pharmaceutical products ever reach actual patients. In this R&D phase, our efforts are always grounded in scientific evidence, nba 結果 we take the patient’s perspective when evaluating the product’s safety nba 結果 efficacy. It is therefore crucial to understnba 結果 conditions in actual healthcare settings; communication with patients nba 結果 healthcare professionals leads to better research nba 結果 development.
We also work hard to train our researchers to a high level of technical competence grounded in a wide range of knowledge nba 結果 tempered by an open, interdisciplinary approach that places priority on corporate ethics. Putting patients first, we will continue improving our R&D capabilities sustainably, provide safe nba 結果 effective products which accurately assess the needs of patients nba 結果 healthcare professionals, nba 結果 keep contributing to people’s health.
In addition to IV solutions, our core product domain nba 結果 a fundamental pillar of medical treatment, nba 結果 medical foods, Otsuka Pharmaceutical Factory engages in R&D to develop products which create new value by meeting unmet medical needs in the fields of surgical aid nba 結果 regenerative medicine products. We see things from the patient’s point of view nba 結果 develop innovative medical products which are not bound by the constraints of existing concepts, nba 結果 undertake all these initiatives with enthusiasm nba 結果 a sense of duty. For example, we are developing a bioengineered pancreatic islet product which could become a major treatment for diabetes patients.
Depending on the circumstances, healthcare professionals often prepare antibiotic solutions or nutrition solutions containing glucose, electrolytes, amino acids, vitamins, trace elements, or all of the above. These solutions are administered intravenously, which is a severe burden for healthcare professionals as it requires an aseptic procedure. We initiated research into the development of a product container that would be both safe nba 結果 easy to use, which resulted in our Otsuka multi-chamber bag system that enables antibiotics nba 結果 solvents to be administered in a sterile environment with a single press. Our antibiotic kit solution, the first of its kind in the world, utilizes this technology. More recently we developed the first-ever quad-chamber bag. These products, which help to prevent medication or mixing errors, have been widely acclaimed by medical institutions.
In 1946 when we began manufacturing various injectable solutions, the container was only made of glass. In order to overcome the disadvantage of a glass container which is heavy nba 結果 easy to break, we developed plastic bottles for the first time in Japan, nba 結果 in addition, we have offered the high-performance soft bags which improved the transparency nba 結果 strength of containers, infection prevention measures, nba 結果 convenience. Putting quality first, we are committed to materials nba 結果 raw materials of containers, nba 結果 we are developing our own containers with our strengths. We will continue to aim for container development that is even more innovative nba 結果 can contribute to the medical field.
Utilizing the technology we have built up in the field of drug development, we have recently begun R&D in the field of medical foods, a growth area in both medical treatment nba 結果 nursing. We plan to extend its research nba 結果 development to products for the global market that contribute to healthcare.
In the event of dehydration caused by diarrhea, vomiting, or fever associated with infectious enteritis or the common cold, or due to excessive sweating or a lack of oral hydration in the elderly, it is essential to quickly replenish water nba 結果 electrolytes. Based on the approach to oral rehydration therapy proposed by the WHO, we developed oral rehydration solution, OS-1, featuring a balance of electrolytes nba 結果 carbohydrates. In December 2004, for the first time in Japan, OS-1 has been approved as a food for persons with medical conditions (individually evaluated type), categorized as a food for special dietary use by the Ministry of Health, Labour nba 結果 Welfare. It is suitable for mild to moderate dehydration nba 結果 is used broadly in clinical nba 結果 nursing care settings.
Dietary intake involves sequential processes ranging from chewing, the formation of food mass, nba 結果 swallowing. PROCESS LEAD, a chew- nba 結果 swallow-managing food, has been developed to have a solid texture when eaten, yet becomes an easily swallowed paste after being chewed. It is a food that meets the needs of medical nba 結果 nursing care settings nba 結果 is designed to be eaten by people with reduced chewing nba 結果 swallowing functions too.